mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.3 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.3 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.3 |